Press release
Anticoagulants Market Poised to Hit $85.87 Billion by 2029 with Accelerating Growth Trends
Anticoagulants Market Size
Anticoagulants Market Size Growth Forecast: What to Expect by 2025?
In recent times, a significant growth has been observed in the size of the anticoagulants market. The market valuation is projected to escalate from $49.33 billion in 2024 to $53.88 billion in 2025, with a compound annual growth rate (CAGR) of 9.2%. Factors such as the aging population, heightened occurrence of cardiovascular diseases, growing awareness about the significance of anticoagulant therapy, the broadening of indications for the usage of anticoagulants, and an increased incidence of venous thromboembolism (VTE) and atrial fibrillation have all contributed to the growth in the historical period.
How Will the Anticoagulants Market Size Evolve and Grow by 2029?
The anticoagulants market is projected to witness substantial growth in the coming years, scaling up to "$85.87 billion by 2029" with a compound annual growth rate (CAGR) of 12.4%. A host of factors are set to contribute to the growth in the forecast period, including the broadening of indications for new anticoagulant drugs, increased healthcare spending, the introduction of novel oral anticoagulants (NOACs) as primary treatments, and financial aid provided by government bodies to improve healthcare facilities, along with the growth of the healthcare infrastructure. The key trends expected to dominate the forecast period include medical and diagnostic technology advancements, the use of artificial intelligence and data analytics in anticoagulant therapy, a heightened focus on patient education and adherence programs, and the emergence of reversal agents.
View the full report here:
https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report
What Drivers Are Propelling the Growth of Anticoagulants Market Forward?
The surge in cardiovascular diseases is a major contributor to the expansion of the anticoagulants market in the forthcoming years. Diseases related to the heart and blood vessels collectively fall under the category of cardiovascular diseases (CVDs). They represent the leading cause of death globally, with low- and middle-income countries responsible for 75% of these fatalities. To mitigate the risk of thrombosis in various cardiovascular conditions, direct oral anticoagulants, a type of anticoagulation pharmacotherapy, are utilized. For example, in May 2024, the Centers for Disease Control and Prevention, a government agency in the US, reported that there were 702,880 deaths in 2022 in the United States due to heart disease, of which 371,506 were due to coronary artery disease. Furthermore, around 805,000 people suffer a heart attack in the country each year. Thus, the escalating prevalence of cardiovascular diseases is fueling the growth of the anticoagulants market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5230&type=smp
Which Emerging Trends Are Transforming the Anticoagulants Market in 2025?
Prominent businesses in the anticoagulants market are centering their efforts on crafting novel solutions like factor Xa inhibitor examinations, due to an amplified requirement for testing stemming from the escalated utilization of direct oral anticoagulants to prevent strokes and manage other grave cardiovascular ailments. Anticoagulant drugs are designed to selectively hinder factor Xa, and Factor Xa Inhibitor Tests are thus used to assess their efficacy and safety, preventing blood clots in various health-related situations. For example, in February 2024, F. Hoffmann-La Roche Ltd., a biotech firm from Switzerland, unveiled their new apixaban, edoxaban, and rivaroxaban coagulation tests. The just-introduced coagulation tests for Factor Xa inhibitors employ Roche's ground-breaking reagent cassette design, assuring top-notch results and productive sample handling, thereby enhancing laboratory workflow through standardization and automation. These tests play a crucial role as they guide clinical judgement for patients dependent on direct oral anticoagulants to forestall strokes, responding to the surging worldwide need for proficient diagnostics in addressing severe issues like coronary artery disease and peripheral arterial disease.
What Are the Key Segments in the Anticoagulants Market?
The anticoagulants market covered in this report is segmented -
1) By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes
2) By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications
5) By End User: Hospitals, Homecare, Specialty Centers, Other End-Users
Subsegments:
1) By Factor Xa Inhibitor: Rivaroxaban, Apixaban, Edoxaban, Betrixaban
2) By Heparin And LMWH (Low Molecular Weight Heparin): Unfractionated Heparin, Enoxaparin, Dalteparin, Tinzaparin
3) By Vitamin K Antagonist: Warfarin, Acenocoumarol, Phenprocoumon
4) By Other Drug Classes: Direct Thrombin Inhibitors, Antiplatelet Agents, Novel Oral Anticoagulants (NOACs)
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=5230&type=smp
Who Are the Key Players Shaping the Anticoagulants Market's Competitive Landscape?
Major companies operating in the anticoagulants market include GlaxoSmithKline plc, Leo Pharma A/S, Alexion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Mylan N. V., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi S. A., Apotex Inc., Aspen Pharmacare Holdings Limited, AstraZeneca plc, Bristol-Myers Squibb Company, CSL Behring, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Fresenius Kabi AG, Hikma Pharmaceuticals plc, Johnson & Johnson, Lupin Limited, Mitsubishi Tanabe Pharma Corporation, Natco Pharma Limited, Novartis International AG, Portola Pharmaceuticals Inc., Strides Pharma Science Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Torrent Pharmaceuticals Limited, Zydus Cadila Healthcare Limited
What Geographic Markets Are Powering Growth in the Anticoagulants Market?
North America was the largest region in the anticoagulants market in 2024. The regions covered in the anticoagulants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5230
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anticoagulants Market Poised to Hit $85.87 Billion by 2029 with Accelerating Growth Trends here
News-ID: 4180256 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Anticoagulant
Anticoagulant Drugs Market Demand Analysis Report 2026
Global Info Research's report offers an in-depth look into the current and future trends in Anticoagulant Drugs, making it an invaluable resource for businesses involved in the sector. This data will help companies make informed decisions on research and development, product design, and marketing strategies. It also provides insights into Anticoagulant Drugs' cost structure, raw material sources, and production processes. Additionally, it offers an understanding of the regulations and policies…
Peptide Anticoagulant Drugs Market Massive Growth opportunity Ahead
Peptide Anticoagulant Drugs market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Peptide Anticoagulant Drugs Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply…
Anticoagulant Rodenticides Market Is Expanding So Quickly
USD Analytics Market recently introduced Global Anticoagulant Rodenticides Market study with 65+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are BASF, Bayer, Syngenta, Rentokil, LiphaTech, JT Eaton, Bell Laboratories,…
Anticoagulant Treatment Market 2021 | Detailed Report
The Anticoagulant Treatment market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Anticoagulant Treatment report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4988667
The Anticoagulant Treatment research report also provides…
Anticoagulants Market To See Record Break Revenue $43.42 Million By 2025 | Vitam …
Anticoagulants are medicinal substances that reduce the coagulation of blood and prolong the clotting time. Anticoagulant drugs achieve their effects by suppressing the synthesis or function of various clotting factors that exist in the blood. The global anticoagulants market is anticipated to show significant market growth during the forecast period, owing to increase in prevalence of ischemic heart disease and venous thromboembolism (VTE) and awareness of novel oral anticoagulants (NOACs).…
Anticoagulant Drugs Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Anticoagulant Drugs market.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/241687/global-anticoagulant-drugs-market
Global Anticoagulant Drugs Market: Forecast by Type / Application / Region
Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
According to this study, over the next five years the Anticoagulant Drugs…
